Sales Growth YoY (Last Twelve Months): Crinetics Corp (CRNX)

Graphic logo of Crinetics Corp (CRNX)

Crinetics Pharmaceuticals (CRNX) is implementing unique oral treatments for rare endocrine pathologies, replacing injections. A diverse range of therapeutic programs minimizes patent and clinical risks. Future monopoly status will allow the company to establish premium pricing for its therapies. This daily price chart of year-over-year sales over 12 months, provided by GURU.Markets, confirms a trend where the indicator level stands at 2919.80.

Sales Growth YoY (Last Twelve Months): Crinetics Pharma (CRNX) for 02/11/2024 - 09/12/2026

Crinetics Pharmaceuticals, Inc. (CRNX) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:Crinetics Pharma
Mass-produced product of Crinetics

For Crinetics Pharmaceuticals (CRNX), this indicator serves as a measure of the commercialization efficiency of innovative treatments for endocrine pathologies. By analyzing the year-over-year (YoY) trend of core revenue over a rolling 12-month period, an investor can track the percentage change in total annual income with daily updates. Growth confirms the scaling of the business driven by physician confidence in the brand's oral medications. Local dips here allow for the differentiation of temporary market corrections from systemic management issues.

Who Crinetics Pharmaceuticals competes with

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)